PT  - JOURNAL ARTICLE
AU  - Lisa Kipersztok
AU  - Gwinyai Masukume
AU  - Julio González-Álvarez
AU  - Victor Grech
TI  - Trends in the Proportion of Women as peer reviewers in JAMA, 2009-2018
AID  - 10.1101/2020.05.12.20088419
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.12.20088419
4099  - http://medrxiv.org/content/early/2020/05/18/2020.05.12.20088419.short
4100  - http://medrxiv.org/content/early/2020/05/18/2020.05.12.20088419.full
AB  - The achievement of gender equity by 2030 is one of the international Sustainable Development Goals adopted by United Nations member states. Peer review is crucial to academia and diverse perspectives add significant value by avoiding publication biases. We investigated the trend in female peer reviewers in JAMA, a globally influential medical journal, over the past decade. Based on publicly available data with a sample size of 33,745, we found an increased proportion of female peer reviewers from 23.9% in 2009, to a peak of 29.1% in 2018. Despite an increase in the proportion of female peer reviewers over the past decade, if we assume a linear trend, gender equity in peer reviewers for JAMA would not be reached until 2065, beyond the 2030 Sustainable Development Goal target.Competing Interest StatementNone declaredFunding StatementThis study did not receive specific fundingAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesPublicly available data was used.